Hepatocellular carcinoma (HCC) is usually connected with high mortality and the

Hepatocellular carcinoma (HCC) is usually connected with high mortality and the current therapy for advanced HCC, Sorafenib, offers limited survival benefits. cells (Mo-MDSC) was also decreased suggesting the reversion of the immunosuppressive growth microenvironment. Our data exhibited that the combinatorial therapy with poly-ICLC XE169 and Sorafenib enhances growth control and regional immune system response therefore… Continue reading Hepatocellular carcinoma (HCC) is usually connected with high mortality and the